2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 5 Phase 1.
By phase and status
Follow BMS-986368: new trials by email Literature Review of BMS-986368 trials Research Report on BMS-986368
Trials (filtered) newest first · largest first
All 5 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Evaluate the Blood Levels, Safety, and Tolerability of BMS-986368 in Healthy Chinese Participants
BMS-986368, BMS-986368-matching Placebo - Healthy Volunteers | Phase 1 | Not yet recruiting | 16 | 2027-01-05 | 2026-07-14 |
A Study to Assess the Relative Bioavailability of Irafamdastat (BMS-986368) and to Assess the Food Effect on the Pharmacokinetics of Irafamdastat in Healthy Adult Participants
Irafamdastat - Healthy Volunteers | Phase 1 | Recruiting | 24 | 2026-10-06 | 2026-11-03 |
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity
BMS-986368 - Healthy Participants | Phase 1 | Completed | 56 | 2024-05-31 | 2024-11-12 |
A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
BMS-986368, Itraconazole, Famotidine - Healthy Participants | Phase 1 | Completed | 32 | 2024-03-18 | 2024-07-01 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants
CC-97489, Placebo - Healthy Volunteers | Phase 1 | Terminated | 84 | 2020-03-13 | 2023-12-14 |
Sponsors
Celgene (5)
Countries
United States (3) · Belgium (1)
NIH funding
2019 (1)